Ignite Creation Date:
2024-05-05 @ 10:22 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006669
Status:
WITHDRAWN
Last Update Posted:
2021-10-27
First Post:
2000-12-06
Brief Title:
Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkins Lymphoma
Sponsor:
Medstar Health Research Institute
Organization:
Medstar Health Research Institute
Organization Data
Organization:
Medstar Health Research Institute
Class:
OTHER
Study ID:
CDR0000068283
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medstar Health Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None